Authors:
PILARSKI LM
YATSCOFF RW
MURPHY GF
BELCH AR
Citation: Lm. Pilarski et al., DRUG-RESISTANCE IN MULTIPLE-MYELOMA - CYCLOSPORINE-A ANALOGS AND THEIR METABOLITES AS POTENTIAL CHEMOSENSITIZERS, Leukemia, 12(4), 1998, pp. 505-509
Authors:
SZCZEPEK AJ
SEEBERGER K
WIZNIAK J
MANT MJ
BELCH AR
PILARSKI LM
Citation: Aj. Szczepek et al., A HIGH-FREQUENCY OF CIRCULATING B-CELLS SHARE CLONOTYPIC IG HEAVY-CHAIN VDJ REARRANGEMENTS WITH AUTOLOGOUS BONE-MARROW PLASMA-CELLS IN MULTIPLE-MYELOMA, AS MEASURED BY SINGLE-CELL AND IN-SITU REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION, Blood, 92(8), 1998, pp. 2844-2855
Authors:
MASELLISSMITH A
BELCH AR
MANT MJ
PILARSKI LM
Citation: A. Masellissmith et al., ADHESION OF MULTIPLE-MYELOMA PERIPHERAL-BLOOD B-CELLS TO BONE-MARROW FIBROBLASTS - A REQUIREMENT FOR CD44 AND ALPHA(4)BETA(7), Cancer research, 57(5), 1997, pp. 930-936
Citation: Lm. Pilarski et al., DEFICIENT DRUG TRANSPORTER FUNCTION OF BONE MARROW-LOCALIZED AND LEUKEMIC PLASMA-CELLS IN MULTIPLE-MYELOMA, Blood, 90(9), 1997, pp. 3751-3759
Authors:
TREON SP
MOLLICK JA
URASHIMA M
TEOH G
CHAUHAN D
OGATA A
NADLER L
PILARSKI LM
BELCH AR
ANDERSON KC
Citation: Sp. Treon et al., MYELOMA CELL-LINES AND MYELOMA PATIENT B-CELL CLONOTYPIC CELLS SELECTIVELY EXPRESS CORE PROTEIN MUC-1 ON THEIR CELL-SURFACE, Blood, 90(10), 1997, pp. 382-382
Citation: Lm. Pilarski et al., CRYPTIC EXPRESSION OF THE CD19 EPITOPE DETECTED BY MAB LEU12 DISTINGUISHES MALIGNANT FROM RESIDUAL POLYCLONAL B-CELLS IN THE BLOOD OF MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 1557-1557
Citation: Aj. Szczepek et al., AUTOCRINE GROWTH-REGULATION OF CIRCULATING CLONOTYPIC B-CELLS IN HUMAN MULTIPLE-MYELOMA - INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR EXPRESSION, Blood, 90(10), 1997, pp. 1566-1566
Citation: Ar. Belch et al., DRUG-RESISTANT MALIGNANT B-CELLS IN MULTIPLE-MYELOMA EXPRESS CD11B AND CLONOTYPIC TRANSCRIPTS, Blood, 90(10), 1997, pp. 2344-2344
Authors:
GATI WP
PATERSON ARP
LARRATT LM
TURNER AR
BELCH AR
Citation: Wp. Gati et al., SENSITIVITY OF ACUTE-LEUKEMIA CELLS TO CYTARABINE IS A CORRELATE OF CELLULAR ES NUCLEOSIDE TRANSPORTER SITE CONTENT MEASURED BY FLOW-CYTOMETRY WITH SAENTA-FLUORESCEIN, Blood, 90(1), 1997, pp. 346-353
Authors:
SZCZEPEK AJ
BERGSAGEL PL
AXELSSON L
BROWN CB
BELCH AR
PILARSKI LM
Citation: Aj. Szczepek et al., CD34(-MYELOMA EXPRESS CD19 AND IGH MESSENGER-RNA AND HAVE PATIENT-SPECIFIC IGH VDJ GENE REARRANGEMENTS() CELLS IN THE BLOOD OF PATIENTS WITH MULTIPLE), Blood, 89(5), 1997, pp. 1824-1833
Authors:
PILARSKI LM
MASELLISSMITH A
SZCZEPEK A
MANT MJ
BELCH AR
Citation: Lm. Pilarski et al., CIRCULATING CLONOTYPIC B-CELLS IN THE BIOLOGY OF MULTIPLE-MYELOMA - SPECULATIONS ON THE ORIGIN OF MYELOMA, Leukemia & lymphoma, 22(5-6), 1996, pp. 375-383
Authors:
MASELLISSMITH A
BELCH AR
OSTERGAARD H
PILARSKI LM
Citation: A. Masellissmith et al., HYALURONAN INDUCTION OF RAF KINASE AND MAP KINASE IN CIRCULATING B-CELLS BUT NOT IN BONE-MARROW PLASMA-CELLS OF MYELOMA PATIENTS, Blood, 88(10), 1996, pp. 397-397
Citation: Lm. Pilarski et al., DNA ANEUPLOIDY AMONG CD19(-CELLS IN MULTIPLE-MYELOMA - DNA CONTENT AND APOPTOTIS AS A FUNCTION OF DIFFERENTIATION STAGE IN THE MYELOMA HIERARCHY() CD38(+) CD34(+) CLONOTYPIC B), Blood, 88(10), 1996, pp. 1545-1545
Authors:
PILARSKI LM
YATSCOFF RW
MURPHY GF
BELCH AR
Citation: Lm. Pilarski et al., CYCLOSPORINE ANALOGS AND METABOLITES AS CHEMOSENSITIZERS IN MULTIPLE-MYELOMA - DIFFERENTIAL DRUG AND DYE RETENTION BY CIRCULATING B-CELLS AS COMPARED TO BONE-MARROW PLASMA-CELLS, Blood, 88(10), 1996, pp. 1546-1546
Citation: Aj. Szczepek et al., IN MULTIPLE-MYELOMA, 10-90-PERCENT OF BLOOD B-CELLS HAVE AN IGH CDR3 IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS, QUANTITATED USING SINGLE-CELL PCR, RT-PCR AND IN-SITU RT-PCR, Blood, 88(10), 1996, pp. 1553-1553
Citation: Ar. Belch et al., CD34(-CELLS IN MULTIPLE-MYELOMA HAVE A REARRANGED IGH VDJ IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS AS QUANTITATED BY IN-SITU RT-PCR() CIRCULATING B), Blood, 88(10), 1996, pp. 1554-1554
Authors:
MASELLISSMITH A
BELCH AR
MANT MJ
TURLEY EA
PILARSKI LM
Citation: A. Masellissmith et al., HYALURONAN-DEPENDENT MOTILITY OF B-CELLS AND LEUKEMIC PLASMA-CELLS INBLOOD, BUT NOT OF BONE-MARROW PLASMA-CELLS, IN MULTIPLE-MYELOMA - ALTERNATE USE OF RECEPTOR FOR HYALURONAN-MEDIATED MOTILITY (RHAMM) AND CD44, Blood, 87(5), 1996, pp. 1891-1899
Citation: Lm. Pilarski et Ar. Belch, INTRINSIC EXPRESSION OF THE MULTIDRUG TRANSPORTER, P-GLYCOPROTEIN-170, IN MULTIPLE-MYELOMA - IMPLICATIONS FOR TREATMENT, Leukemia & lymphoma, 17(5-6), 1995, pp. 367-374
Authors:
BELCH AR
EISENHAUER EA
MULDAL A
BROWMAN G
KLASA R
OSTERWALDER B
Citation: Ar. Belch et al., PHASE-II STUDY OF SUBCUTANEOUS RHU-INTERLEUKIN-2 AND RHU-INTERFERON ALPHA-2A IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE-MYELOMA, Annals of oncology, 6(7), 1995, pp. 721-723
Authors:
ALESSISEVERINI S
GATI WP
BELCH AR
PATERSON ARP
Citation: S. Alessiseverini et al., INTRACELLULAR PHARMACOKINETICS OF 2-CHLORODEOXYADENOSINE IN LEUKEMIA-CELLS FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(10), 1995, pp. 1674-1679
Authors:
PILARSKI LM
PAINE D
MCELHANEY JE
CASS CE
BELCH AR
Citation: Lm. Pilarski et al., MULTIDRUG TRANSPORTER P-GLYCOPROTEIN-170 AS A DIFFERENTIATION ANTIGENON NORMAL HUMAN-LYMPHOCYTES AND THYMOCYTES - MODULATION WITH DIFFERENTIATION STAGE AND DURING AGING, American journal of hematology, 49(4), 1995, pp. 323-335
Authors:
PILARSKI LM
SZCZEPEK A
MACDONALD H
MANT MJ
BELCH AR
Citation: Lm. Pilarski et al., SINGLE-CELL IGH CDR3 PCR AND IN-SITU RT-PCR FOR IGH CDR3 AND IG LIGHT-CHAIN UNEQUIVOCALLY CONFIRM THAT CIRCULATING CD19(-MYELOMA ARE B-CELLS() CELLS IN MULTIPLE), Blood, 86(10), 1995, pp. 219-219
Authors:
MASELLISSMITH A
BELCH AR
TURLEY EA
MANT MJ
PILARSKI LM
Citation: A. Masellissmith et al., DIFFERENTIAL USAGE OF RHAMM AND CD44 DURING MIGRATION OF B-LINEAGE CELLS IN MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 236-236